doc. MUDr. Jana Štefaničková, PhD.

Vedecko/umelecko-pedagogická charakteristika:

 

Najvýznamnejšie výstupy tvorivej činnosti: VTC1, VTC2, VTC3, VTC4, VTC5

1.

Stefanickova J, Cunha-Vaz J, Ulbig M, Pearce I, Fernández-Vega Sanz A, et al.; POLARIS study investigators. A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS). Acta Ophthalmolologica. 2018 

 Q1

 IF 3,153

2.

Krasnik V, Stefanickova J, Popov I, Valaskova J, Saxena S, Kruzliak P. Prevalence of Age-Related Macular Degeneration in Slovakia and Associated Risk Factors: A Mobile Clinic-Based Cross-Sectional Epidemiological Survey. Seminars in Ophthalmology. 2018 

 Q4

 IF 1,401

3.

Ankita A, Saxena S, Nim DK, Stefanickova J, Ziak P, Stefanicka P, Kruzliak P. Retinal photoreceptor apoptosis is associated with impaired serum ionized calcium homeostasis in diabetic retinopathy: An in-vivo analysis. Journal of Diabetes and its Complications. 2019 

 Q3

 IF 2,781

4.

Ankita A, Stefanickova J, Saxena S, Nim DK, Ahmad K, Mahdi AA, Kaur A, Bhasker SK, Valaskova J, Kruzliak P. Hyperglycemia potentiates the effect of ionic calcium in photoreceptor ellipsoid zone disruption in diabetic retinopathy. International Ophthalmology. 2019 

 Q2

 IF 1,314

5.

Garweg JG, Štefanickova J, Hoyng C, Niesen T, Schmelter T, Leal S, Sivaprasad S; VIOLET Investigators. Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial. Advances in therapy. 2022 

 Q1

 IF 3,847